Eli Lilly drug gets FDA nod for emergency use with remdesivir to treat COVID-19 – Reuters UK

Eli Lilly drug gets FDA nod for emergency use with remdesivir to treat COVID-19 – Reuters UK

The U.S. Food and Drug Administration on Thursday approved the emergency use of Eli Lilly and Co’s arthritis drug, baricitinib, in combination with Gilead Sciences Inc’s remdesivir, to treat COVID-19 patients.

Read More…

You May Also Like